Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Cash & Current Investments (2016 - 2025)

Amn Healthcare Services (AMN) has disclosed Cash & Current Investments for 16 consecutive years, with $34.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 219.02% year-over-year to $34.0 million, compared with a TTM value of $34.0 million through Dec 2025, up 219.02%, and an annual FY2025 reading of $34.0 million, up 219.02% over the prior year.
  • Cash & Current Investments was $34.0 million for Q4 2025 at Amn Healthcare Services, down from $52.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $180.9 million in Q4 2021 and bottomed at $7.0 million in Q2 2023.
  • Average Cash & Current Investments over 5 years is $70.6 million, with a median of $52.6 million recorded in 2025.
  • The sharpest move saw Cash & Current Investments plummeted 91.16% in 2023, then soared 584.99% in 2024.
  • Year by year, Cash & Current Investments stood at $180.9 million in 2021, then plummeted by 64.34% to $64.5 million in 2022, then tumbled by 48.96% to $32.9 million in 2023, then tumbled by 67.67% to $10.6 million in 2024, then skyrocketed by 219.02% to $34.0 million in 2025.
  • Business Quant data shows Cash & Current Investments for AMN at $34.0 million in Q4 2025, $52.6 million in Q3 2025, and $41.5 million in Q2 2025.